Synthetic biology refers to artificial design and construction of genetic parts and biology systems, which is based on genetic engineering of systematic biology. We firstly review the development status of synthetic biology, the ethical issue, and the safety issue it may cause to the environment and public health. Europe and America support the development of synthetic biology while continuing to improve their management mechanisms. In view of the fact that domestic synthetic biology is still in its infancy, we recommend some corresponding countermeasures in the development of systematic biology based on the lessons from others countries, including strengthening risk assessment in the application and research of synthetic biology, improving supervision and management systems, strengthening biosafety and bioethics education, and promoting exchanges with the international community.
LIANG Huigang
,
HUANG Cui
,
SONG Donglin
,
CHEN Zongsheng
,
YUAN Zhiming
. Biosafety issue on researches and applications of Synthetic Biology[J]. Science & Technology Review, 2016
, 34(2)
: 307
-312
.
DOI: 10.3981/j.issn.1000-7857.2016.2.052
[1] Brian J Y, Wendell A L. Synthetic biology: Lessons from the history of syn-thetic organic chemistry[J]. Nature Chemical Biology, 2007, 3: 521-525.
[2] Stéphane Leduc. The mechanism of life[M]. United States of America: Kessinger Publishing, 1911.
[3] Hobom B. Genesurgery: On the threshold of synthetic biology[J]. Med-izinische Klinik, 1980, 75(24): 834-841.
[4] 李晶, 李思思, 魏强, 等. 合成生物学的生物安全问题及对策分析[J]. 中国医学装备, 2013, 10(6): 68-71. Li Jing, Li Sisi, Wei Qiang, et al. Synthetic biology: Biosafety and manage-ment strategy analysis[J]. China Medical Equipment, 2013, 10(6): 68-71.
[5] Ro D K, Paradise E M, Ouellet M, et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast[J]. Nature, 2006, 440: 940-943.
[6] Gibson D G, Glass J I, Lartigue C, et al. Creation of a bacterial cell con-trolled by a chemically synthesized genome[J]. Science, 2010, 329: 52-56.
[7] The Presidential Commission for the Study of Bioethical Issues. New di-rections:The ethics of synthetic biology and emerging technologies[EB/ OL]. 2013-12-16. http://bioethics.gov/sites/default/files/PCSBI-Synthet-ic-Biology-Report-12.16.10_0.pdf.
[8] The White House. National bioeconomy blueprint[EB/OL]. 2013-04-08. https://www.whitehouse.gov/sites/default/files/microsites/ostp/natioal_bio -economy_blueprint_april_2012.pdf.
[9] The Defense Advanced Research Projects Agency (DARPA). DARPA opens biotech office to utilize biology for national defense[EB/OL]. 2014-04-21. http://www.darpa.mil/NewsEvents/Releases/2014/04/01.aspx.
[10] ERASynBio. Next steps for european synthetic biology: A strategic vision from ERASynBio[EB/OL]. 2014-05-22. http://biologie-synthese.cnam.fr/medias/fichier/erasynbio-strategic-vision-synthetic-biology_1399627 533667-pdf.
[11] HM Government. A UK strategy for agricultural technologies[EB/OL]. 2013-07-15. https://www.gov.uk/government/uploads/system/uploads/at-tachment_data/file/227259/9643-BIS-UK_Agri_Tech_Strategy_Acces-sible.pdf.
[12] Planning Commission Government of India. Twelfth five year plan 2012-17[EB/OL]. 2012-08-13. http://planningcommission.gov.in/plans/plan-rel/12thplan/welcome.html.
[13] Woodrow Wilson International Center for Scholars. Updated map tracks global growth of synthetic biology[EB/OL]. 2013-05-10. http://www.syn-bioproject.org/map.
[14] Valda Vinson, Elizabeth Pennisi. The allure of synthetic biology[EB/OL]. 2015-05-05. http://www.ebiotrade.com/newsf/2011-9/20119217114293 8.htm.
[15] 贾斌, 李炳志, 元英进. 合成生物学展望[J]. 中国科学, 2014, 9(44): 1455-1460. Jia Bin, Li Bingzhi, Yuan Yingjin. Prospects of synthetic biology[J]. Sci-entia Sinica Chimica, 2014, 9(44): 1455-1460.
[16] Cello J, Paul A V, Wimmer E. Chemical synthesis of poliovirus cDNA: Generation of infections virus in the absence of natural template[J]. Sci-ence, 2002, 297: 1016-1018.
[17] Smith H O, Hutchison C A, Pfannkoch C, et al. Generating a synthetic genome by whole genome assembly: ФΧ174 bacteriophage from synthet-ic oligonucleotides[J]. Processdings of the National Academy of Scienc-es, 2003, 100: 15440-15445.
[18] Kobasa D, Takada A, Shinya K, et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus[J]. Nature, 2004, 431: 703-707.
[19] Becker M M, Graham R L, Donaldson E F, et al. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice[J]. Processdings of the National Academy of Sciences, 2008, 105: 19944-19949.
[20] Masaki I, Tokiko W, Masato H, et al. Experimental adaptation of an influ-enza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets[J]. Nature, 2012, 486: 420-428.
[21] Sander Herfst, Eefje Schrauwen, Martin Linster, et al. Airborne transmis-sion of influenza A/H5N1 virus between ferrets[J]. Science, 2012, 336: 1534-1541.
[22] 熊燕, 陈大明, 杨琛, 等. 合成生物学发展现状与前景[J]. 生命科学, 2011, 23(9): 826-837 Xiong Yan, Chen Daming, Yang Chen, et al. Progress and perspective of synthetic biology[J]. Chinese Bulletin of Life Sciences, 2011, 23(9): 826-837.
[23] AGETC, Friends of the Earth. The principles for the oversight of synthet-ic biology[EB/OL]. 2012-08-18. http://libcloud.s3.amazonaws.com/93/ ae/9/2287/2/Principles_for_the_oversight_of_synthetic_biology.pdf.
[24] WHO. Guidance for adoption of appropriate risk control measures to con-duct safe research on H5N1 transmission[EB/OL]. 2012-07-30. http:// www.who.int/influenza/human_animal_interface/avian_influenza/ h5n1_research/Biosafety_summary.pdf?ua=1.
[25] BWC Member States. Report the meeting of states parties[EB/OL]. 2012-12-14. http://www.unog.ch/80256EDD006B8954/%28httpAssets%29/52 E8FF218F8C4F0FC1257AD400606647/$file/BWC+MSP+2012+-+Ad-vance+Report.pdf.
[26] UNODA. The biological weapons convention[EB/OL]. 2012-04-10. http: //www.un.org/disarmament/WMD/Bio.
[27] WHO. International health regulations[EB/OL]. 2013-09-16. http://apps. who.int/iris/bitstream/10665/43883/1/9789241580410_eng.pdf.
[28] 郭安凤, 陈东立, 李逸民, 等. 生物技术的两用性及其监控措施[J]. 生物技术通讯, 2005, 16(6): 653-656. Guo Anfeng, Chen Dongli, Li Yimin, et al. Dual-use of biotechnology and its oversight measures[J]. Letters in Biotechnology, 2005, 16(6): 653-656.
[29] NSABB. Addressing biosecurity concerns related to synthetic biology[EB/ OL]. 2010-06-12. http://oba.od.nih.gov/.
[30] GPO. United States code[EB/OL]. 2012-09-02. http://uscode.house.gov/ download/download.shtml;jsessionid=A7488F4DC759C31A7B0E05BAB 98771F6.
[31] The National Science Advisory Board for Biosecurity(NSABB). Address-ing biosecurity concerns related to synthetic biology[EB/OL]. 2010-04-30. http://osp.od.nih.gov/sites/default/files/Relman_NSABB%20SB%201 20309.pdf.
[32] NSABB. United States Government policy for oversight of life science du-al use resarch of concern[EB/OL]. 2013-01-11. http://oba.od.nih.gov/ oba/biosecurity/PDF/United_States_Government_Policy_for_Oversight_ of_DURC_FINAL_version_032812.pdf.
[33] OSTP. United States Government policy for oversight of life sciences du-al use research of concern[EB/OL]. 2013-05-26. http://www.phe.gov/s3/ dualuse/Documents/us-policy-durc-032812.pdf.
[34] OSTP. United States Government policy for institutional oversight of life sciences dual use research of concern[EB/OL]. 2013-04-26. http://www. phe.gov/s3/dualuse/Documents/oversight-durc.pdf.
[35] NIH. NIH guidelines for research involving recombinant or synthetic nu-cleic acid molecules[EB/OL]. 2013-05-11. http://osp.od.nih.gov/sites/ default/files/NIH_Guidelines_0.pdf.
[36] Schauzu M. The European Union's regulatory framework on genetically modified organisms and derived foods and feeds[J]. Advancements in Ge-netic Engineering, 2013, (2): 109.
[37] Health and Safety Executive(HSE). The genetically modified organisms (containeduse)(amendment)regulations[EB/OL].2010-11-25. http://www. hse.gov.uk/biosafety/gmo/guidance/amendingregs.pdf.
[38] EASAC.RealisingEuropeanpotentialinsyntheticbiology:Scientificoppor-tunities and good governance[EB/OL]. 2010-12-30. https://www.cbd.int/ doc/emerging-issues/emergingissues-2013-10-EASAC-SyntheticBiolo-gy-en.pdf.
[39] German Ethics Council. German ethics council: Government should regu-late dangerous research[EB/OL]. 2014-05-07. http://news.sciencemag. org/europe/2014/05/german-ethics-council-government-should-regu-late-dangerous-research.
[40] RAE. Synthetic biology: Public dialogue on synthetic biology[EB/OL]. 2012-06-06. http://www.raeng.org.uk/publications/reports/syn-bio-dia-logue-report.
[41] 中共中央关于制定国民经济和社会发展第十二个五年规划的建议 [EB/OL]. 2012-10-28. http://politics.people.com.cn/GB/1026/1306619 0.html.
[42] 中华人民共和国科学技术部. 关于印发十二五现代生物制造科技发展专项规划的通知[EB/OL]. 2011-12-02. http://www.most.gov.cn/tztg/ 201112/t20111209_91321.htm.
[43] 中华人民共和国科学技术部. 科技部关于发布国家重点基础研究发展计划和重大科学研究计划2014年项目申报指南的通知[EB/OL]. 2013-01-31. http://www.most.gov.cn/mostinfo/xinxifenlei/fgzc/gfxwj/gfx-wj2013/201303/t20130315_100221.htm.
[44] 我国合成生物学发展现状——对话中科院合成生物学重点实验室主任赵国屏院士[EB/OL]. 2011-10-19. http://www.bioon.com/master/ talent/507806.shtml.
[45] 中华人民共和国农业部科技教育司. 农业生物基因工程安全管理实施办法[EB/OL]. 2012-03-02. http://www.moa.gov.cn/sjzz/kjs/fagui/ 200403/t20040302_1833334.htm.
[46] 中华人民共和国农业部. 农业转基因生物安全评价管理办法[EB/ OL]. 2012-03-04. http://www.moa.gov.cn/zwllm/zcfg/nybgz/200806/ t20080606_1057067.htm.
[47] 刘晓, 唐鸿铃. 合成生物学及其安全监管[J]. 生命的化学, 2012, 32 (6): 580-584. Liu Xiao, Tang Hongling. Synthetic biology and its safety supervision[J]. Chemistry of Life, 2012, 32(6): 580-584.
[48] 中国科学院北京生命科学研究所. 合成生物学的伦理问题与生物安全学术研讨会召开[EB/OL]. 2012-07-01. http://www.biols.cas.cn/xwdt/ zhxw/201007/t20100701_2890628.html.
[49] 益西达娃. 合成生物学研究进展及前景分析[J]. 佳木斯教育学院学报, 2013(10): 20-21. Yixidawa. Analysis of progress and prospect of synthetic biology[J]. Jour-nal of Jiamusi Education Institute, 2013(10): 20-21.
[50] 王方, 王慧媛, 陈大明, 等. 合成生物学发展的情报分析[J]. 生命的化学, 2013, 33(2): 19-25. Wang Fang, Wang Huiyuan, Chen Daming, et al. Intelligence analysis of the development of synthetic biology[J]. Chemistry of Life, 2013, 33(2): 19-25.
[51] 高超. 合成生物学的安全问题和管理建议[J]. 科技创新, 2013, 185: 213. Gao Chao. The safety problems and management recommendations of synthetic biology[J]. Scientific and Technological Innovation, 2013, 185: 213.
[52] 郑涛, 黄培堂, 沈培奋. 当前国际生物安全形势与展望[J]. 军事医学, 2012, 36(10): 721-724. Zheng Tao, Huang Peitang, Shen Beifen. Status and prospect of global bi-osecurity[J]. Military Medical Sciences, 2012, 36(10): 721-724.
